Literature DB >> 12472179

Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals.

Kersti Klaamas1, Oleg Kurtenkov, Kate Rittenhouse-Olson, Vadim Brjalin, Ljudmila Miljukhina, Ljudmila Shljapnikova, Lars Engstrand.   

Abstract

We tested the hypothesis that the gastric cancer associated bacteria, Helicobacter pylori (H. pylori) express the cancer-related Thomsen-Friedenreich (T) antigen. We also analysed whether infection with H. pylori alters the amount of natural anti-T antibodies in the patients' sera. Cell surface membrane extracts of H. pylori NCTC 11637 strain and clinical isolates of H. pylori (n = 13) were analysed by immunoblotting and cell-ELISA with five different T antigen-specific monoclonal antibodies (MAbs). Two major protein bands of approximately 68 kDa and 58 kDa were immunostained on blots of H. pylori extracts with T specific MAbs but not immunostained with unrelated MAb. The specificity was shown in that immunostaining was blocked with peanut agglutinin (PNA) and rabbit antiserum to T antigen. The binding of T specific MAb to the 58 kDa protein band was also blocked by rabbit antiserum against heat shock proteins of H. pylori. The relative expression of T antigen-related proteins differed among H. pylori strains, with 68 kD associated T antigen expression higher in patients with more severe pathology. The level of IgG antibody to T epitope in patients with gastric cancer (n = 66) and normal blood donors (n = 62) were compared and the level of anti-T Ab in gastric cancer patients was significantly lower than that in normal blood donors. A significant positive correlation between T specific antibody in serum and H. pylori IgG antibody level was found in H. pylori-infected normal blood donors (P < 0.001), but this correlation was not found in H. pylori-infected cancer patients. In summary, the cancer related T epitope is expressed in H. pylori and modulation of T antigen-specific immune response in H. pylori-infected individuals suggests that H. pylori infection may alter natural immune mechanisms against cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12472179     DOI: 10.1081/imm-120016240

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  10 in total

Review 1.  Cancer vaccines and carbohydrate epitopes.

Authors:  Jamie Heimburg-Molinaro; Michelle Lum; Geraldine Vijay; Miten Jain; Adel Almogren; Kate Rittenhouse-Olson
Journal:  Vaccine       Date:  2011-10-01       Impact factor: 3.641

2.  Inhibition of spontaneous breast cancer metastasis by anti-Thomsen-Friedenreich antigen monoclonal antibody JAA-F11.

Authors:  Jamie Heimburg; Jun Yan; Susan Morey; Olga V Glinskii; Virginia H Huxley; Linda Wild; Robert Klick; Rene Roy; Vladislav V Glinsky; Kate Rittenhouse-Olson
Journal:  Neoplasia       Date:  2006-11       Impact factor: 5.715

3.  Immunophenotyping at the time of diagnosis distinguishes two groups of nasopharyngeal carcinoma patients: implications for adoptive immunotherapy.

Authors:  Jiang Li; Qiu-yan Chen; Haoyuan Mo; Yi-lan Zhang; Zhou-feng Huang; Yi-xin Zeng
Journal:  Int J Biol Sci       Date:  2011-05-18       Impact factor: 6.580

4.  Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.

Authors:  Tatiana Pochechueva; Francis Jacob; Andre Fedier; Viola Heinzelmann-Schwarz
Journal:  Metabolites       Date:  2012-11-14

5.  The relation of the level of serum anti-TF, -Tn and -alpha-Gal IgG to survival in gastrointestinal cancer patients.

Authors:  Eugeniy Smorodin; Boris Sergeyev; Kersti Klaamas; Valentin Chuzmarov; Oleg Kurtenkov
Journal:  Int J Med Sci       Date:  2013-09-23       Impact factor: 3.738

6.  Increased sialylation of anti-Thomsen-Friedenreich antigen (CD176) antibodies in patients with gastric cancer: a diagnostic and prognostic potential.

Authors:  Oleg Kurtenkov; Jelena Izotova; Kersti Klaamas; Boris Sergeyev
Journal:  Biomed Res Int       Date:  2014-09-04       Impact factor: 3.411

7.  Anti-Glycan Autoantibodies Induced by Helicobacter pylori as a Potential Risk Factor for Myocardial Infarction.

Authors:  Riccardo Negrini; Vincenzo Villanacci; Claudio Poiesi; Antonella Savio
Journal:  Front Immunol       Date:  2020-04-08       Impact factor: 7.561

Review 8.  Prospects and Challenges of the Study of Anti-Glycan Antibodies and Microbiota for the Monitoring of Gastrointestinal Cancer.

Authors:  Eugeniy P Smorodin
Journal:  Int J Mol Sci       Date:  2021-10-27       Impact factor: 5.923

9.  Repertoire of BALB/c Mice Natural Anti-Carbohydrate Antibodies: Mice vs. Humans Difference, and Otherness of Individual Animals.

Authors:  Daniel Bello-Gil; Nailya Khasbiullina; Nadezhda Shilova; Nicolai Bovin; Rafael Mañez
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

Review 10.  Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential.

Authors:  Oleg Kurtenkov
Journal:  Biomed Res Int       Date:  2020-03-23       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.